Erubin 50mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Epirubicin (50mg)
Overview Erubin 50mg Injection
Erubin 50mg Injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your doctor based on your condition and may vary. Strict adherence to your doctor's instructions is vital; incorrect usage can lead to severe adverse reactions. Benefits may take weeks or months to appear; discontinue only under medical supervision. Erubin reduces contraceptive efficacy; reliable contraception is recommended for both partners throughout treatment. Common side effects include nausea, low platelet count, alopecia, amenorrhea, fever, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests monitor blood cell levels and kidney, liver, and heart function. Disclose any liver or heart conditions, and all other medications to your doctor before starting treatment, as interactions may impact Erubin's effectiveness. Inform your doctor of pregnancy or breastfeeding.
Uses of Erubin 50mg Injection
Malignant neoplasm
Major Benefits of Erubin 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Erubin 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Erubin 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Erubin 50mg Injection works:
Erubin 50mg Injection is a cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of damaging free radicals, leads to DNA disruption, ultimately hindering the growth and causing the death of breast cancer cells.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Erubin 50mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Erubin 50mg Injection during pregnancy poses a confirmed risk to the fetus, making it inadvisable. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Erubin 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Erubin 50mg Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Erubin 50mg Injection, can temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
Erubin 50mg Injection appears safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, however, consultation with a physician is recommended. For patients exhibiting serum creatinine levels exceeding 5 mg/dL, reduced dosages should be explored.
LiverCAUTION
Caution is advised when administering Erubin 50mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. Erubin 50mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Erubin 50mg Injection :
NA
Facts to Know About Erubin 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently